- During 2010-2015, use of active surveillance nearly tripled in patients with low-risk prostate cancer.
- Black patients were less likely to receive active surveillance compared with nonblack patients.
- Socioeconomic and insurance status may be associated with lower odds of active surveillance in black patients.
Why this matters
- Black patients are underrepresented in clinical trials that evaluated active surveillance.
- Studies to guide management for black men with low-risk prostate cancer are warranted.
- Study of 50,302 patients with low-risk prostate cancer between 2010 and 2015.
- Funding: American Society for Radiation Oncology; the Prostate Cancer Foundation.
- 14.9% of patients were black.
- During 2010-2015, the use of radical prostatectomy and definitive radiotherapy decreased:
- Black patients: from 41.4% and 46.0% to 28.8% and 34.8%, respectively (P<.001>
- Nonblack patients: from 48.5% and 36.7% to 31.8% and 24.9%, respectively (P<.001>
- Black patients: 12.6% to 36.4% (P<.001>
- Nonblack patients: 14.8% to 43.3% (P<.001>
- Black men had lower odds of receipt of active surveillance vs nonblack men (aOR, 0.93; P=.02); the association was not significant after adjusting for socioeconomic and insurance status (aOR, 1.01; P=.86).
- Observational design.